- Friday 1st of October 2021
anti-HIgG(Fc)Fab-C-MMAE ADC
The anti-HIgG(Fc)Fab-C-MMAE ADC is a powerful antibody-drug conjugate designed to target specific antigens with high precision. By combining the targeting ability of the anti-HIgG(Fc)Fab fragment with the potent cytotoxic agent C-MMAE, this ADC offers a promising therapeutic option for treating various cancers. The unique structure ensures targeted delivery of the drug to cancer cells, minimizing off-target effects and enhancing the overall therapeutic efficacy. As research into ADCs advances, the anti-HIgG(Fc)Fab-C-MMAE ADC continues to show potential in revolutionizing cancer treatment strategies.
Latest News
- Friday 1st of October 2021
“BIZ 2021” Entrepreneurial Day competition
- Friday 1st of October 2021
Workshop on modern assessment and the Use of Zoom Software in Learner-Centered Classroom (Academic staff)
- Friday 19th of March 2021
“Let’s Plant Trees for a Better Environment 2021”
- Friday 19th of March 2021
Biz 2020 – UWU Entrepreneurs’ Day
- Friday 19th of March 2021
Faculty of Management signs MoU with the Sri Lanka Institute of Marketing
- Friday 19th of March 2021
0 Replies:
Leave a Reply